GHENT, Belgium, 4 January 2012 - Ablynx [Euronext Brussels: ABLX] today announced that it plans to webcast its corporate presentation at the 30th Annual J.P. Morgan Healthcare Conference on Wednesday, 11 January 2012 at 03:30 p.m. PST / 00:30 a.m. CET.

The presentation, followed by a Q&A, will be hosted by Dr Edwin Moses, CEO and Chairman of Ablynx. The presentation will be webcast live and may be accessed on the home page of the Ablynx website at www.ablynx.com:
http://www.ablynx.com/en/. Shortly thereafter, a replay of the webcast will be available on the Company's website for 30 days following the presentation.

To ensure a timely connection, it is recommended that users register at least 10 minutes prior to the scheduled webcast.

About Ablynx

Ablynx:
http://www.ablynx.com/en/ (Euronext: ABLX) is a biopharmaceutical company engaged in the discovery and development of Nanobodies®:
http://www.ablynx.com/en/research-development/nanobody-technology/understanding-nanobodies/, a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious and life-threatening human diseases, including inflammation, haematology, oncology and pulmonary disease. Today, the Company has over 25 programmes in the pipeline:
http://www.ablynx.com/en/research-development/pipeline/ and seven Nanobodies in clinical development. Ablynx has ongoing research collaborations and significant partnerships with major pharmaceutical companies, including Boehringer Ingelheim, Merck Serono, Novartis, and has had a collaboration with Pfizer. The Company is headquartered in Ghent, Belgium and currently employs over 290 people. More information can be found on www.ablynx.com:
http://www.ablynx.com/en/.

For more information, please contact Ablynx:

Dr Edwin Moses
Chairman and CEO
t:   +32 (0)9 262 00 07
m: +44 (0)7771 954 193 /
     +32 (0)473 39 50 68
e:  edwin.moses@ablynx.com:
mailto:edwin.moses@ablynx.com

Marieke Vermeersch
Investor Relations Manager
t:   +32 (0)9 262 00 82
m: +32 (0)479 49 06 03
e:  marieke.vermeersch@ablynx.com :
mailto:marieke.vermeersch@ablynx.com%20

Complete version of the press release:
http://hugin.info/137912/R/1575161/490539.pdf


This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Ablynx via Thomson Reuters ONE
HUG#1575161